Nguyen Team Unveils HealTEC Stem Cell Therapy, Cutting Immunogenicity After Long-Term Storage
Updated
Updated · Nature.com · Jun 29
Nguyen Team Unveils HealTEC Stem Cell Therapy, Cutting Immunogenicity After Long-Term Storage
1 articles · Updated · Nature.com · Jun 29
Summary
HealTEC packages mesenchymal stem cell-derived, non-living therapies into off-the-shelf formulations that stayed therapeutically stable after long-term storage under mild conditions while showing lower immunogenicity than living-cell injections in mice.
The platform combines high-dose tannic acid cell inactivation, low-temperature cellular matter condensation and lyophilization to preserve structure and therapeutic cargo that is often lost in current non-living cell manufacturing.
Three versions were demonstrated: immunomodulatory factor-enriched formulations for ulcerative colitis, angiogenic factor-enriched formulations for hindlimb ischaemia, and nanoparticle-loaded lung-targeting formulations for asthma.
Patent filings span 5 jurisdictions—Korea, Japan, China, the US and PCT—underscoring the authors' push to scale manufacturing and commercialize a cell-therapy approach aimed at broader clinical use.
Could this 'off-the-shelf' cell therapy make today's billion-dollar living drugs obsolete?
Can a non-living cell truly replicate healing power without introducing unique long-term risks?
HealTEC Unveiled: The First Off-the-Shelf, Non-Living Stem Cell Therapy Platform Tackling Immunogenicity and Global Accessibility
Overview
HealTEC, unveiled by the Nguyen Team in 2026, introduces a groundbreaking approach to stem cell therapy by creating non-living stem cell products through tannic acid engineering and lyophilization. This innovation directly addresses major challenges in traditional cell therapies, such as maintaining cell viability, complex storage needs, and immunogenicity. By engineering stable, off-the-shelf cellular depots, HealTEC makes advanced therapies more accessible and practical. The platform’s novel methodology not only simplifies logistics but also paves the way for safer and more widely available regenerative treatments, marking a significant advancement in the field.